✨ Free AI Report
CeriBell, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research CeriBell, Inc.
Company Research

CeriBell, Inc.: Business Overview, Financials & Competitive Analysis

CeriBell, Inc. scores 4/10 on the AskCyborg Cyborg Score (Mixed). Growth-stage medical technology with validated AI-powered diagnostic innovation and strong analyst support, but profitability remains a near-term risk. CeriBell had a negative return on equity of 31.77% and a negative net margin of 59.97% in Q4 2025. The company has a market cap of $680.62 million, a PE ratio of.

What is CeriBell, Inc.'s industry? CeriBell, Inc. (ceribell.com) operates in Medical Devices & Technology - Neurological Diagnostics / Point-of-Care EEG. AskCyborg classifies CeriBell, Inc. under Medical Devices & Technology - Neurological Diagnostics / Point-of-Care EEG in its company registry.

CeriBell is a healthcare technology company specializing in the design, manufacture and sale of automated newborn hearing screening devices, offering a suite of medical diagnostic tools based on otoacoustic emissions ...

4/ 10Mixed

Cyborg Score thesis

Growth-stage medical technology with validated AI-powered diagnostic innovation and strong analyst support, but profitability...

Read the full analyst-debate transcript →
Industry Medical Devices & Technology - Neurological Diagnostics / Point-of-Care EEG
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest CeriBell, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for CeriBell, Inc.

AskCyborg analysts argue the bull and bear cases for CeriBell, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
CeriBell, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

CeriBell, Inc. Overview

Pro stress-test →

CeriBell is a healthcare technology company specializing in the design, manufacture and sale of automated newborn hearing screening devices, offering a suite of medical diagnostic tools based on otoacoustic emissions (OAE) and auditory brainstem response (ABR) technologies. The company's solutions are used in hospitals, birthing centers and audiology clinics to support universal newborn hearing screening programs. However, the company has evolved to also focus on acute care neurological diagnostics through point-of-care EEG technology.

Strategic Profile

Pro stress-test →

CeriBell is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions through the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform. The system combines proprietary, highly portable, and rapidly deployable hardware with sophisticated artificial intelligence-powered algorithms. The company received FDA 510(k) clearance for its Clarity algorithm, becoming the first and only AI-powered point-of-care EEG system cleared to detect electrographic seizures, supported by data from over 1,700 patients.

Competitive Landscape

Pro stress-test →

CeriBell operates in the small-cap medical device space alongside competitors like Nephros. The point-of-care EEG market is nascent with limited direct competition. The company's AI-powered Clarity algorithm and FDA clearance for seizure detection in pediatric and adult populations (1+ years) represent significant competitive advantages. Indirect competition exists from traditional ICU EEG monitoring and software vendors.

Industry Context

CeriBell, Inc. operates in Medical Devices & Technology - Neurological Diagnostics / Point-of-Care EEG.

Key facts

Founded: 2014 · Headquarters: Sunnyvale, CA, United States · Employees: 281 · Revenue: $85-88M (FY 2025E, 30-34% growth projected) · Market cap: $680.62M - $784.95M

What the analysts stress-tested

The top findings that survived the multi-agent debate for CeriBell, Inc..

  • Q4 2025 performance driven by product revenue of $15.9 million (up 38%) and subscription revenue of $5.3 million (up 41%).
  • The company maintains a strong financial position with $177.4 million in cash and equivalents.
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • February 2026Q4 2025 earnings beat: reported ($0.36) EPS vs. ($0.43) estimate; revenue $24.78M beat expectations
  • August 2025CEO Jane Chao presented at Canaccord Genuity 45th Annual Growth Conference
  • +1 moreTrack every material event for CeriBell, Inc. as it happens. Explore monitoring →
Get alerted when CeriBell, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Traditional EEG Monitoring SystemsBedside EEG systems without portable, point-of-care capability→Cloud-based EEG Management PlatformsRemote EEG review and interpretation software (non-portable hardware)→Hearing Screening Devices (legacy business)Automated newborn hearing screening solutions→

Compare CeriBell, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

CeriBell, Inc. operates in Medical Devices & Technology - Neurological Diagnostics / Point-of-Care EEG. See how the rest of the sector scores on the Cyborg framework.

Browse Medical Devices & Technology - Neurological Diagnostics / Point-of-Care EEG research →
NEW · MCP server

Ask your AI assistant about CeriBell, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare CeriBell, Inc. and its top competitor on Cyborg Score”
“What did CeriBell, Inc. do this quarter?”
“Is CeriBell, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does CeriBell, Inc. do?+
CeriBell is a healthcare technology company specializing in the design, manufacture and sale of automated newborn hearing screening devices, offering a suite of medical diagnostic tools based on otoacoustic emissions ...
What is CeriBell, Inc.'s Cyborg Score?+
CeriBell, Inc. has a Cyborg Score of 4/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are CeriBell, Inc.'s main competitors?+
Named competitors include Traditional EEG Monitoring Systems, Cloud-based EEG Management Platforms, Hearing Screening Devices (legacy business). The full competitive landscape is in the AskCyborg report.
How can I get the full CeriBell, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the CeriBell, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track CeriBell, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.